Translation and Validation of the Brazilian-Portuguese Short Version of Vascular Quality of Life Questionnaire in Peripheral Artery Disease Patients with Intermittent Claudication Symptoms

Correia, Marília de Almeida; Andrade-Lima, Aluísio; Longano, Paulo; Domiciano, Rômulo M.; Domingues, Wagner Jorge Ribeiro; Wolosker, Nelson; Puench-Leão, Pedro; Ritti‐Dias, Raphael Mendes; Cucato, Gabriel Grizzo

doi:10.1016/j.avsg.2018.02.026

Cited by 16 publications

(16 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A good correlation with domains SF-12 score and excellent responsiveness to changes were demonstrated. This study maintains, with respect to the original version and with other validation carried out, the psychometric properties of the VascuQoL-6 health-related quality of life questionnaire (4,6,9,18,20).…”

Section: Discussionmentioning

confidence: 70%

Cross Cultural Adaptation and Validation of a Spanish Version of VascuQol-6 Questionnaire.

Soria-Juan

Llanos

Moral

et al. 2021

Preprint

View full text Add to dashboard Cite

Background:Outcomes in peripheral arterial disease (PAD) are usually clinical alone, ignoring patient´s bio-psychological sphere. VascuQol-6 is a specific questionnaire aimed to asses quality of life of patients suffering PAD. Our objective was to carry out a cross-cultural adaptation and validation of VQ-6 questionnaire from original English version into Spanish, in order to have a rapid, sensitive and easy-to-apply clinical tool for evaluating HRQoL outcomes in PAD patients.MethodsA prospective study with 100 outpatients with PAD patients was carried out in two university hospitals. Patients completed the Spanish translated VasquQol-6 (VQ-6) questionnaire and the SF-12 questionnaire. Validation of the VQ-6 Spanish Version was assessed through statistical measurement of reliability, reproducibility and validity of the questionnaire. Reproducibility of the Spanish VQ-6 was assessed through Intraclass Correlation Coefficient, while Internal consistency was analyzed through Alpha Cronbach. Criterion Validity was assessed by comparing the SF-12 and with Pearson’s Correlation Coefficient. Construct Validity was assessed by comparing the results of the questionnaire with the stage of the PAD based on Rutherford-Becker Category.ResultsOn hundred patients were included in the study from July 2019 to January 2021. 82 % were male with a median age of 71.6 years. The reproducibility of the VQ-6 Spanish Version in each item was evaluated in a sample of 80 patients. Pain, Activity, Social and Emotional domains had ICC values ranging from 0.70 to 0.88, indicating a good agreement. The value obtained for Cronbach's Alpha was 0.89 using all the questions of the questionnaire, indicating a good internal consistency. VQ-6 and SF-12 showed positive correlations. The overall Pearson Correlation Coefficient was 0.77 for Physical SF-12, indicating an elevated Criterion Validity. Under´s curve area was 0.8, so discrimination capacity of VQ-6 Spanish Version to discriminate between IC and CLI was considered good.ConclusionVQ-6 Spanish Version is a reliable and valid instrument for evaluation of quality of life in patients suffering from PAD that can be used in clinical practice, adding a decision-base when evaluating different treatment options. This VQ-6 Spanish Version is intended to cover the spectrum of severity of PAD in Spanish-speaking patients.Trial registration: ClinicalTrials.gov NCT04741321. Retrospectively registered on February 05,2021)

show abstract

Section: Discussionmentioning

confidence: 70%

Cross Cultural Adaptation and Validation of a Spanish Version of VascuQol-6 Questionnaire.

Soria-Juan

Llanos

Moral

et al. 2021

Preprint

View full text Add to dashboard Cite

show abstract

“…Since this study was conducted, the validity and test retest reliability of VQ-6 have been tested in a Swedish population of mainly CLI (70%) [19], and the validity in a Brazilian PAD population with intermittent claudication [20]. Experience with the instrument are emerging also from the national vascular registry of Sweden, Swedvasc [21].…”

Section: Discussionmentioning

confidence: 99%

Self-reported health status and disease-specific quality of life one year after treatment for peripheral arterial disease in clinical practice

Larsen

Reiersen

Nådland

et al. 2020

Health Qual Life Outcomes

View full text Add to dashboard Cite

Background: VascuQoL-6 (VQ-6) is a disease-specific quality of life (QoL) instrument validated for use in clinical practice and vascular registries before and after treatment for peripheral arterial disease (PAD). To improve future interpretation of self-reported outcome, an unselected cohort was followed through one year to provide observational data after both conservative and invasive treatment. Methods: Consecutive patients with intermittent claudication (IC) or critical limb ischemia (CLI) were included. All patients completed VQ-6 and Short Form-36 (SF-36), and were evaluated with ankle-brachial index (ABI) measurement pre-and post-exercise, a constant load treadmill test and clinical consultation at baseline and after one year. Change statistics and correlation analysis were used to describe self-reported outcome after conservative and invasive treatment for PAD. Results: One hundred seventy-one patients with peripheral arterial disease (PAD) were included, 70 (41%) female. 147 (86%) of the patients suffered from IC. 136 (80%) patients had one-year follow up, death, amputation and withdrawal were the major causes of loss to follow-up. Forty-eight patients (35%) evaluated their health to be unchanged compared to one year ago. There was a strong correlation between self-reported general health status based on SF-36 item 2 and VQ-6 summary score (Spearmans rho = − 0.536). Patients admitted to invasive intervention (endovascular or surgery) improved in all domains of SF-36, and in the physical component summary score (SF-36 PCS). Patients admitted to best medical treatment, smoking cessation and walking exercise (conservative group) improved only in the physical domains. There was significant improvement in VQ-6 summary score for both groups, mean 2.20 (95%CI 1.14-3.27) in the conservative group, 4.68 (95%CI 3.67-5.70) in the invasive group. VQ-6 sum score improved more than four points for 56% in the invasive group, 36% in the conservative group. Conclusions: Treatment for symptomatic PAD, both invasive and conservative, improves self-reported health status and disease specific QoL after one year. Interpretation of patient-reported outcome measured with VQ-6 after surgery or endovascular treatment must be seen in light of the improvement from conservative treatment alone.

show abstract

“…Vascular quality of life questionnaire– 6 . The quality of life will be evaluated by the vascular quality of life questionnaire VascuQoL-6, as previously described [ 35 ]. The questionnaire is composed of six items to evaluate the impact of disease on social aspects and the capacity to perform daily activities.…”

Section: Methodsmentioning

confidence: 99%

Effects of arm-crank exercise on cardiovascular function, functional capacity, cognition and quality of life in patients with peripheral artery disease: Study protocol for a randomized controlled trial

et al. 2022

Self Cite

View full text Add to dashboard Cite

Background Arm-crank exercise training (ACT) is an alternative exercise strategy for patients with symptomatic peripheral artery disease (PAD) due to the attenuation of pain symptoms during the exercise, as well as the benefits to functional capacity. Purpose The aim of this study is to describe the study protocol to analyze the effects of ACT exercise on cardiovascular function, functional capacity, cognition and quality of life in patients with symptomatic PAD. Methods This is a three-armed randomized, prospective, single-blind data collection, single-center, controlled study enrolling 45 patients with symptomatic PAD who will be randomized into 3 intervention groups: walking training (WT), ACT and control group. The WT and ACT will perform 2 sessions/week, 15 to 10 sets of 2 to 5 minutes at values of 13 to 15 on the Borg scale. Before and after 12 weeks of intervention, cardiovascular function (ambulatory blood pressure, office blood pressure, central blood pressure, heart rate variability, arterial stiffness and vascular function), functional capacity (six-minute walk test, 2 minute step test, handgrip test, Walking impairment questionnaire, Walking estimated limitation calculated by history, Baltimore activity scale for intermittent claudication, and short physical performance battery), cognition (executive function and memory), and quality of life (vascular quality of life questionnaire and World Health Organization Quality of Life) will be assessed. Results This is the first trial to evaluate the effects of ACT on regulatory mechanisms of the cardiovascular system in PAD patients. If the results are as expected, they will provide evidence the ability of ACT to promote cardiovascular benefits in the symptomatic PAD population.

show abstract

Translation and Validation of the Brazilian-Portuguese Short Version of Vascular Quality of Life Questionnaire in Peripheral Artery Disease Patients with Intermittent Claudication Symptoms

Cited by 16 publications

References 25 publications

Cross Cultural Adaptation and Validation of a Spanish Version of VascuQol-6 Questionnaire.

Cross Cultural Adaptation and Validation of a Spanish Version of VascuQol-6 Questionnaire.

Self-reported health status and disease-specific quality of life one year after treatment for peripheral arterial disease in clinical practice

Effects of arm-crank exercise on cardiovascular function, functional capacity, cognition and quality of life in patients with peripheral artery disease: Study protocol for a randomized controlled trial

Contact Info

Product

Resources

About